-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 10, the website of the Hunan Provincial Medical Insurance Bureau announced the list of the first batch of "dual-channel" management designated medical institutions at the provincial level, including 17 medical institutions such as Hunan Cancer Hospital, Hunan Maternal and Child Health Hospital, and Yifeng University.
20 retail pharmacies including Changsha Chaoyang Branch of Pharmacy Chain Co.
, Ltd.
and Shaoshan South Road Branch of Hunan Jinxiang Pharmaceutical Chain Co.
,
Ltd.
"Dual-channel" refers to the two channels of designated medical institutions and designated retail pharmacies to meet the reasonable needs of negotiating drug supply security, clinical use, etc.
, and simultaneously include the mechanism of medical insurance payment
.
In May 2021, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiated Drugs" (hereinafter referred to as the "Guiding Opinions"), which will include designated retail pharmacies in the negotiation of drug supply.
The scope of protection is clearly implemented, and the "dual-channel" management mechanism for negotiated drugs is clearly implemented
.
The implementation of this policy is conducive to giving full play to the advantages of pharmacies with wide distribution, high marketization and flexible services, improving the level of negotiated drug supply guarantee, improving the availability of drugs for patients, and protecting the interests of insured patients
.
Compared with ordinary fixed-point retail pharmacies, pharmacies that meet the "dual-channel" management need to meet higher requirements in terms of informatization, drug management and supervision, and DTP pharmacies have a high degree of conformity with the selection criteria
.
Under the influence of this policy, more and more traditional pharmacies will transform into DTP pharmacies, and DTP pharmacies will usher in good development opportunities
.
Helping to solve the problem of "difficulty in hospital admission" for some negotiated drugs.
National medical insurance drug negotiation and centralized procurement with volume are two major measures implemented by the National Medical Insurance Administration in the reform of the medical and health system since its establishment.
After the drug is negotiated into the medical insurance catalog, it does not mean that it can directly enter the hospital pharmacy and be included in the hospital catalog
.
The following 5 steps are required for a drug to enter the hospital catalog smoothly
.
First, after evaluating the risks and benefits of the drug, the clinician submits a drug application to the department; second, the department conducts a preliminary selection; third, the hospital medical committee conducts a formal review of the drug production license and other documents; fourth, the hospital regularly convenes In the drug selection meeting for new drugs admitted to the hospital, the applicant will focus on the reasons for drug application, comparison with existing drugs, irreplaceability, etc.
Experts will ask questions and discuss and vote independently, and the final approval votes will exceed 2/3 of the number of experts participating in the meeting.
In order to pass; Fifth, the hospital selects the distribution supplier of the drug in the hospital from the bid-winning suppliers, announces the meeting and suspension of the drug on the hospital intranet, and the pharmacy department performs the procurement task
.
The "Guiding Opinions" for the first time included designated retail pharmacies in the scope of medical insurance drug supply guarantee at the national level, and implemented a unified payment policy with medical institutions, which essentially guides patients to flow to retail pharmacies, which is conducive to solving the "difficulty in hospital admission" for some medical insurance negotiated drugs.
"problem
.
The "Guiding Opinions" clarifies that the scope of drugs included in the "dual-channel" management is, in principle, determined by the provincial medical insurance administrative department according to procedures
.
It is necessary to comprehensively consider factors such as the level of economic development, the affordability of medical insurance funds, and the needs of patients for medication, and implement classified management of negotiated drugs.
For varieties with high clinical value, urgent needs of patients, and low substitution, they should be included in the scope of "dual-channel" drug management in a timely manner.
.
"Dual-channel" drugs can be adjusted periodically as circumstances change
.
Various places have implemented the establishment of a "dual-channel" management mechanism.
In September 2021, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Notice on Adapting to the Normalization of National Medical Insurance Negotiations and Continuing to Do a Good Job in Negotiating Drugs".
There is a clear time requirement for the implementation of the drug: "In principle, before the end of October 2021, each province should determine the list of drugs that are included in the 'dual-channel' management and announce it to the public
.
Before the end of November 2021, each province should realize the Level cities (prefectures, leagues) have at least 1 qualified 'dual-channel' retail pharmacy, and can provide corresponding drug supply guarantee services
.
" From May 2021 to now, in addition to Hunan, there are also Guangdong, Fujian, Anhui , Jiangxi, Jiangsu, Sichuan, Qinghai and other provinces have successively issued documents to implement the establishment of a "dual-channel" management mechanism
.
In September 2021, the Guangdong Provincial Medical Insurance Bureau, the Provincial Health and Health Commission, and the Provincial Food and Drug Administration jointly issued the "Implementation Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Nationally Talked Drugs", which clarified that all parts of the province will be required before January 1, 2022.
Formulate and issue detailed implementation rules, and put forward requirements for the establishment of a "dual-channel" management mechanism from various aspects, including determining the scope of "dual-channel" management of drugs, strengthening the supply guarantee of "dual-channel" drugs, establishing a "dual-channel" designated retail pharmacy management mechanism, Improve the circulation of external prescriptions and drug purchase management, unify medical insurance payment policies and medical insurance payment standards, and promote Internet + "dual-channel" drug circulation services
.
In September of the same year, the Fujian Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the "Notice on Establishing a "Dual Channel" Management Mechanism for Drugs Negotiated by National Medical Insurance" (hereinafter referred to as the "Notice"), which clearly established the province's "Dual Channel" management of drugs negotiated by the state.
mechanism, and announced the first batch of "dual-channel" management drug catalogs, including a total of 32 kinds of drugs
.
At the same time, it is clarified that designated retail pharmacies that meet the following conditions can apply to the medical insurance department of the overall planning area to be included in the "dual-channel" management: no medical insurance agreement has been suspended by the medical security department due to violations of laws, regulations and agreements in the past three years; registered licensed pharmacists are not less than 2 name; the business scope of the drug business license includes biological products; it has the conditions for electronic drug traceability and cold chain service management capabilities; it is equipped with no less than 30% of the varieties in the "dual-channel" drug catalog, and is compatible with drug manufacturers (imported drugs can be Is the domestic general agent) signed a supply cooperation agreement
.
In December of the same year, the Fujian Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the "Notice on Accelerating the Landing of National Negotiated Drugs in 2021", which will add 67 nationally negotiated drugs to the National Medical Insurance Drug List in 2021 and include them in Fujian Province's "Double Drugs".
"Channel" to manage the scope of drugs, implement the relevant management regulations of the "Notice", and implement it simultaneously with the new version of the National Medical Insurance Drug List
.
The deferasirox dispersible tablets and adalimumab injection in the first batch of "dual-channel" drugs were adjusted to the regular list drugs in the new version of the National Medical Insurance Drug List, and will no longer be included in the "dual-channel" drug list from January 1, 2022 "Management
.
"Dual-channel" management promotes the development of DTP pharmacies The designated retail pharmacies included in the "dual-channel" management have higher requirements in terms of informatization, drug management, talent allocation and medical insurance fund supervision
.
In terms of informatization, designated retail pharmacies should connect with medical insurance information platforms, electronic prescription circulation platforms, etc.
to ensure comprehensive, accurate and timely communication of information on drugs and medical insurance payments; in terms of drug management, some negotiated drugs have special requirements for storage, and designated retail Pharmacies need to establish a storage and distribution system that meets the requirements to ensure the quality and safety of drugs, and at the same time provide professional personnel to guide patients on rational drug use to ensure the safety of clinical drug use; in terms of medical insurance fund supervision, designated retail pharmacies should take stricter measures.
Carry out verification to ensure that "prescribed patients" and "actual medication patients" are consistent, plug the "fraud and fraudulent insurance" loopholes, and ensure the safety of medical insurance funds
.
DTP pharmacy refers to a pharmacy that provides more valuable professional services directly to patients, specializing in or concurrently operating drugs for the treatment of special diseases, and licensed pharmacists or pharmacists provide patients with long-term, professional and personalized drug treatment management; Special requirements for service environment, facilities and distribution conditions, complete information management system, and traceable quality assurance
.
The DTP pharmacy model skips the circulation links such as agents and drug bidding, and simplifies the circulation chain (the circulation chain of the DTP pharmacy model is shown in the figure)
.
Doctors exchange prescription information with DTP pharmacies, establish a communication and feedback mechanism between the two parties, and jointly provide patients with safe and accurate medication services
.
The software and hardware conditions of DTP pharmacies are in good agreement with the selection criteria of "dual-channel" pharmacies, and they have more selection advantages than ordinary retail pharmacies
.
The implementation of the "dual channel" management mechanism will promote the transformation of more traditional retail pharmacies to DTP pharmacies, and DTP pharmacies will usher in good development opportunities
.
(Contributed by Toubao Research Institute) Related Links According to statistics from the Toubao Research Institute, the DTP pharmacy market in China will reach 19 billion yuan in 2020, and it is expected that the market will reach 38.
3 billion yuan in 2024 at a compound annual growth rate of 19.
2%
.
At present, there are three categories of companies involved in the DTP pharmacy industry in China - pharmaceutical commercial companies, traditional retail chain pharmacies and Internet big data technology companies
.
Among them, more resource-rich commercial companies have the highest market share
.
Many pharmaceutical commercial companies have transformed into self-built DTP pharmacies, which have extensive cooperation foundations with pharmaceutical industry enterprises, strong hospital market development capabilities and outstanding logistics capabilities, such as Sinopharm, China Resources and Shanghai Pharma
.
Traditional retail chain pharmacies have been transformed into prescription drug sales and operated in a shop-in-shop mode focusing on high-end prescription drugs DTP.
It has the advantages of wide distribution of chain pharmacies, many types of cooperation with pharmaceutical industry enterprises, and rich experience in patient member management.
Yifeng Pharmacy,
etc.
Internet big data technology companies empower DTP formats with new technologies, innovate multi-dimensional services, and are committed to building smart DTP pharmacies, such as Linke, Sipai, Yuanxin Technology,
etc.
20 retail pharmacies including Changsha Chaoyang Branch of Pharmacy Chain Co.
, Ltd.
and Shaoshan South Road Branch of Hunan Jinxiang Pharmaceutical Chain Co.
,
Ltd.
"Dual-channel" refers to the two channels of designated medical institutions and designated retail pharmacies to meet the reasonable needs of negotiating drug supply security, clinical use, etc.
, and simultaneously include the mechanism of medical insurance payment
.
In May 2021, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for National Medical Insurance Negotiated Drugs" (hereinafter referred to as the "Guiding Opinions"), which will include designated retail pharmacies in the negotiation of drug supply.
The scope of protection is clearly implemented, and the "dual-channel" management mechanism for negotiated drugs is clearly implemented
.
The implementation of this policy is conducive to giving full play to the advantages of pharmacies with wide distribution, high marketization and flexible services, improving the level of negotiated drug supply guarantee, improving the availability of drugs for patients, and protecting the interests of insured patients
.
Compared with ordinary fixed-point retail pharmacies, pharmacies that meet the "dual-channel" management need to meet higher requirements in terms of informatization, drug management and supervision, and DTP pharmacies have a high degree of conformity with the selection criteria
.
Under the influence of this policy, more and more traditional pharmacies will transform into DTP pharmacies, and DTP pharmacies will usher in good development opportunities
.
Helping to solve the problem of "difficulty in hospital admission" for some negotiated drugs.
National medical insurance drug negotiation and centralized procurement with volume are two major measures implemented by the National Medical Insurance Administration in the reform of the medical and health system since its establishment.
After the drug is negotiated into the medical insurance catalog, it does not mean that it can directly enter the hospital pharmacy and be included in the hospital catalog
.
The following 5 steps are required for a drug to enter the hospital catalog smoothly
.
First, after evaluating the risks and benefits of the drug, the clinician submits a drug application to the department; second, the department conducts a preliminary selection; third, the hospital medical committee conducts a formal review of the drug production license and other documents; fourth, the hospital regularly convenes In the drug selection meeting for new drugs admitted to the hospital, the applicant will focus on the reasons for drug application, comparison with existing drugs, irreplaceability, etc.
Experts will ask questions and discuss and vote independently, and the final approval votes will exceed 2/3 of the number of experts participating in the meeting.
In order to pass; Fifth, the hospital selects the distribution supplier of the drug in the hospital from the bid-winning suppliers, announces the meeting and suspension of the drug on the hospital intranet, and the pharmacy department performs the procurement task
.
The "Guiding Opinions" for the first time included designated retail pharmacies in the scope of medical insurance drug supply guarantee at the national level, and implemented a unified payment policy with medical institutions, which essentially guides patients to flow to retail pharmacies, which is conducive to solving the "difficulty in hospital admission" for some medical insurance negotiated drugs.
"problem
.
The "Guiding Opinions" clarifies that the scope of drugs included in the "dual-channel" management is, in principle, determined by the provincial medical insurance administrative department according to procedures
.
It is necessary to comprehensively consider factors such as the level of economic development, the affordability of medical insurance funds, and the needs of patients for medication, and implement classified management of negotiated drugs.
For varieties with high clinical value, urgent needs of patients, and low substitution, they should be included in the scope of "dual-channel" drug management in a timely manner.
.
"Dual-channel" drugs can be adjusted periodically as circumstances change
.
Various places have implemented the establishment of a "dual-channel" management mechanism.
In September 2021, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Notice on Adapting to the Normalization of National Medical Insurance Negotiations and Continuing to Do a Good Job in Negotiating Drugs".
There is a clear time requirement for the implementation of the drug: "In principle, before the end of October 2021, each province should determine the list of drugs that are included in the 'dual-channel' management and announce it to the public
.
Before the end of November 2021, each province should realize the Level cities (prefectures, leagues) have at least 1 qualified 'dual-channel' retail pharmacy, and can provide corresponding drug supply guarantee services
.
" From May 2021 to now, in addition to Hunan, there are also Guangdong, Fujian, Anhui , Jiangxi, Jiangsu, Sichuan, Qinghai and other provinces have successively issued documents to implement the establishment of a "dual-channel" management mechanism
.
In September 2021, the Guangdong Provincial Medical Insurance Bureau, the Provincial Health and Health Commission, and the Provincial Food and Drug Administration jointly issued the "Implementation Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Nationally Talked Drugs", which clarified that all parts of the province will be required before January 1, 2022.
Formulate and issue detailed implementation rules, and put forward requirements for the establishment of a "dual-channel" management mechanism from various aspects, including determining the scope of "dual-channel" management of drugs, strengthening the supply guarantee of "dual-channel" drugs, establishing a "dual-channel" designated retail pharmacy management mechanism, Improve the circulation of external prescriptions and drug purchase management, unify medical insurance payment policies and medical insurance payment standards, and promote Internet + "dual-channel" drug circulation services
.
In September of the same year, the Fujian Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the "Notice on Establishing a "Dual Channel" Management Mechanism for Drugs Negotiated by National Medical Insurance" (hereinafter referred to as the "Notice"), which clearly established the province's "Dual Channel" management of drugs negotiated by the state.
mechanism, and announced the first batch of "dual-channel" management drug catalogs, including a total of 32 kinds of drugs
.
At the same time, it is clarified that designated retail pharmacies that meet the following conditions can apply to the medical insurance department of the overall planning area to be included in the "dual-channel" management: no medical insurance agreement has been suspended by the medical security department due to violations of laws, regulations and agreements in the past three years; registered licensed pharmacists are not less than 2 name; the business scope of the drug business license includes biological products; it has the conditions for electronic drug traceability and cold chain service management capabilities; it is equipped with no less than 30% of the varieties in the "dual-channel" drug catalog, and is compatible with drug manufacturers (imported drugs can be Is the domestic general agent) signed a supply cooperation agreement
.
In December of the same year, the Fujian Provincial Medical Insurance Bureau and the Provincial Health and Health Commission jointly issued the "Notice on Accelerating the Landing of National Negotiated Drugs in 2021", which will add 67 nationally negotiated drugs to the National Medical Insurance Drug List in 2021 and include them in Fujian Province's "Double Drugs".
"Channel" to manage the scope of drugs, implement the relevant management regulations of the "Notice", and implement it simultaneously with the new version of the National Medical Insurance Drug List
.
The deferasirox dispersible tablets and adalimumab injection in the first batch of "dual-channel" drugs were adjusted to the regular list drugs in the new version of the National Medical Insurance Drug List, and will no longer be included in the "dual-channel" drug list from January 1, 2022 "Management
.
"Dual-channel" management promotes the development of DTP pharmacies The designated retail pharmacies included in the "dual-channel" management have higher requirements in terms of informatization, drug management, talent allocation and medical insurance fund supervision
.
In terms of informatization, designated retail pharmacies should connect with medical insurance information platforms, electronic prescription circulation platforms, etc.
to ensure comprehensive, accurate and timely communication of information on drugs and medical insurance payments; in terms of drug management, some negotiated drugs have special requirements for storage, and designated retail Pharmacies need to establish a storage and distribution system that meets the requirements to ensure the quality and safety of drugs, and at the same time provide professional personnel to guide patients on rational drug use to ensure the safety of clinical drug use; in terms of medical insurance fund supervision, designated retail pharmacies should take stricter measures.
Carry out verification to ensure that "prescribed patients" and "actual medication patients" are consistent, plug the "fraud and fraudulent insurance" loopholes, and ensure the safety of medical insurance funds
.
DTP pharmacy refers to a pharmacy that provides more valuable professional services directly to patients, specializing in or concurrently operating drugs for the treatment of special diseases, and licensed pharmacists or pharmacists provide patients with long-term, professional and personalized drug treatment management; Special requirements for service environment, facilities and distribution conditions, complete information management system, and traceable quality assurance
.
The DTP pharmacy model skips the circulation links such as agents and drug bidding, and simplifies the circulation chain (the circulation chain of the DTP pharmacy model is shown in the figure)
.
Doctors exchange prescription information with DTP pharmacies, establish a communication and feedback mechanism between the two parties, and jointly provide patients with safe and accurate medication services
.
The software and hardware conditions of DTP pharmacies are in good agreement with the selection criteria of "dual-channel" pharmacies, and they have more selection advantages than ordinary retail pharmacies
.
The implementation of the "dual channel" management mechanism will promote the transformation of more traditional retail pharmacies to DTP pharmacies, and DTP pharmacies will usher in good development opportunities
.
(Contributed by Toubao Research Institute) Related Links According to statistics from the Toubao Research Institute, the DTP pharmacy market in China will reach 19 billion yuan in 2020, and it is expected that the market will reach 38.
3 billion yuan in 2024 at a compound annual growth rate of 19.
2%
.
At present, there are three categories of companies involved in the DTP pharmacy industry in China - pharmaceutical commercial companies, traditional retail chain pharmacies and Internet big data technology companies
.
Among them, more resource-rich commercial companies have the highest market share
.
Many pharmaceutical commercial companies have transformed into self-built DTP pharmacies, which have extensive cooperation foundations with pharmaceutical industry enterprises, strong hospital market development capabilities and outstanding logistics capabilities, such as Sinopharm, China Resources and Shanghai Pharma
.
Traditional retail chain pharmacies have been transformed into prescription drug sales and operated in a shop-in-shop mode focusing on high-end prescription drugs DTP.
It has the advantages of wide distribution of chain pharmacies, many types of cooperation with pharmaceutical industry enterprises, and rich experience in patient member management.
Yifeng Pharmacy,
etc.
Internet big data technology companies empower DTP formats with new technologies, innovate multi-dimensional services, and are committed to building smart DTP pharmacies, such as Linke, Sipai, Yuanxin Technology,
etc.
